Association Between the Insulin-like Growth Factor 1 Gene Rs2195239 and Rs2162679 Polymorphisms and Cancer Risk: a Meta-analysis

Overview

Journal BMC Med Genet

Publisher Biomed Central

Specialty Genetics

Date 2019 Jan 19

PMID 30654740

Citations 7

Authors

Gui-Ping Xu

Wei-Xian Chen

Qing Zhao

Hua Zhou

Shi-Zhi Chen

Li-Fang Wu

Affiliations

Soon will be listed here.

Abstract

Background: Many epidemiological studies have suggested that insulin-like growth factor1 (IGF1) gene single-nucleotide polymorphisms (SNPs) may be associated with cancer risk. Among several commonly studied polymorphisms in IGF1 gene, rs2195239 and rs2162679 attracted many attentions. So we perform a meta-analysis to determine potential associations between IGF1 rs2195239 and rs2162679 polymorphisms and cancer risk.

Methods: We retrieved relevant articles from the PubMed, Embase, and Web of Science databases up to April 30, 2018. Ultimately, thirteen studies were included in the present meta-analysis, which involved 12,515 cases and 19,651 controls. The odd ratios (ORs) and their 95% confidence intervals (CIs) were pooled to estimate the strength of the associations.

Results: rs2195239 reduces the overall cancer risk in homozygote model, as well as reducing cancer risk in Asian populations in allele, homozygote, and recessive models. No significant relationship was found between rs2195239 and breast or pancreatic cancer risk. rs2162679 reduces the overall cancer risk in allele, homozygote, dominant, and recessive models, as well as reducing cancer risk in Asian populations in allele, homozygote, and recessive models.

Conclusions: IGF1 rs2195239 and rs2162679 were associated with overall cancer risk based on present studies.

Citing Articles

The G allele of the IGF1 rs2162679 SNP is a potential protective factor for any myopia: Updated systematic review and meta-analysis.

Meng B, Wang K, Huang Y, Wang Y PLoS One. 2022; 17(7):e0271809.

PMID: 35862416 PMC: 9302841. DOI: 10.1371/journal.pone.0271809.

Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.

Cowan D, Moncrieffe D Drug Test Anal. 2021; 14(5):808-819.

PMID: 34418311 PMC: 9545871. DOI: 10.1002/dta.3155.

A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk.

Ye Z, Li L, Luo M, Qing H, Zheng J, Zhang C Aging (Albany NY). 2020; 12(24):25256-25274.

PMID: 33226370 PMC: 7803556. DOI: 10.18632/aging.104128.

Breast Cancer Risk Prediction in Korean Women: Review and Perspectives on Personalized Breast Cancer Screening.

Kim D, Park H J Breast Cancer. 2020; 23(4):331-342.

PMID: 32908785 PMC: 7462811. DOI: 10.4048/jbc.2020.23.e40.

A comprehensive assessment of single nucleotide polymorphisms associated with pancreatic cancer risk: A protocol for systematic review and network meta-analysis.

Ye Z, Li L, Zheng J, Zhang C, Lu Y, Tang Y Medicine (Baltimore). 2020; 99(24):e20345.

PMID: 32541456 PMC: 7302655. DOI: 10.1097/MD.0000000000020345.

References

Tian X, Dai S, Sun J, Jiang S, Jiang Y . Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies. Sci Rep. 2016; 6:24097. PMC: 4823650. DOI: 10.1038/srep24097. View

Xu G, Chen W, Xie W, Wu L . The association between IGF1 gene rs1520220 polymorphism and cancer susceptibility: a meta-analysis based on 12,884 cases and 58,304 controls. Environ Health Prev Med. 2018; 23(1):38. PMC: 6094919. DOI: 10.1186/s12199-018-0727-y. View

Mao J, Zhuang G, Chen Z . Genetic Polymorphisms of Insulin-Like Growth Factor 1 Are Associated with Osteosarcoma Risk and Prognosis. Med Sci Monit. 2017; 23:5892-5898. PMC: 5735675. DOI: 10.12659/msm.908004. View

Chia V, Sakoda L, Graubard B, Rubertone M, Chanock S, Erickson R . Risk of testicular germ cell tumors and polymorphisms in the insulin-like growth factor genes. Cancer Epidemiol Biomarkers Prev. 2008; 17(3):721-6. DOI: 10.1158/1055-9965.EPI-07-0768. View

Birmann B, Tamimi R, Giovannucci E, Rosner B, Hunter D, Kraft P . Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma. Cancer Epidemiol Biomarkers Prev. 2009; 18(1):282-8. PMC: 2661109. DOI: 10.1158/1055-9965.EPI-08-0778. View

Shi J, Aronson K, Grundy A, Kobayashi L, Burstyn I, Schuetz J . Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk. Front Oncol. 2016; 6:136. PMC: 4896919. DOI: 10.3389/fonc.2016.00136. View

Dong X, Li Y, Tang H, Chang P, Hess K, Abbruzzese J . Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Cancer Epidemiol. 2011; 36(2):206-11. DOI: 10.1016/j.canep.2011.05.013. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Hall K, Hilding A, Thoren M . Determinants of circulating insulin-like growth factor-I. J Endocrinol Invest. 1999; 22(5 Suppl):48-57. View

10.

Lonn S, Rothman N, Shapiro W, Fine H, Selker R, Black P . Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol. 2008; 10(4):553-9. PMC: 2666228. DOI: 10.1215/15228517-2008-026. View

11.

Lu L, Wang F, He L, Xue Y, Wang Y, Zhang H . Interaction Between IGF1 Polymorphisms and the Risk of Acute Lymphoblastic Leukemia in Chinese Children. Cell Physiol Biochem. 2015; 36(4):1346-58. DOI: 10.1159/000430301. View

12.

Poole E, Tworoger S, Hankinson S, Baer H . Genetic variability in IGF-1 and IGFBP-3 and body size in early life. BMC Public Health. 2012; 12:659. PMC: 3508796. DOI: 10.1186/1471-2458-12-659. View

13.

Rodriguez S, Gaunt T, Day I . Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease. Hum Genet. 2007; 122(1):1-21. DOI: 10.1007/s00439-007-0378-3. View

14.

Renehan A, Harvie M, Howell A . Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer. 2006; 13(2):273-8. DOI: 10.1677/erc.1.01219. View

15.

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

16.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

17.

Verhaeghe J, Loos R, Vlietinck R, Herck E, Van Bree R, Schutter A . C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in cord serum of twins: genetic versus environmental regulation. Am J Obstet Gynecol. 1996; 175(5):1180-8. DOI: 10.1016/s0002-9378(96)70025-x. View

18.

Nakao M, Hosono S, Ito H, Watanabe M, Mizuno N, Yatabe Y . Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. Int J Mol Epidemiol Genet. 2011; 2(4):354-66. PMC: 3243451. View

19.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

20.

Canzian F, McKay J, Cleveland R, Dossus L, Biessy C, Rinaldi S . Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer. 2006; 94(2):299-307. PMC: 2361124. DOI: 10.1038/sj.bjc.6602936. View